Adenocarcinoma, Sebaceous

"Adenocarcinoma, Sebaceous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant tumor composed of cells showing differentiation toward sebaceous epithelium. The tumor is solitary, firm, somewhat raised, more or less translucent, and covered with normal or slightly verrucose epidermis. It may be yellow or orange. The face and scalp are the commonest sites. The growth can be slow or rapid but metastasis is uncommon. Surgery cures most of the cases. (From Rook et al., Textbook of Dermatology, 4th ed, pp2403-4)

Descriptor ID	D018266
MeSH Number(s)	C04.557.470.200.025.105 C04.557.470.550.105
Concept/Terms	Adenocarcinoma, Sebaceous Adenocarcinoma, Sebaceous Adenocarcinomas, Sebaceous Sebaceous Adenocarcinoma Sebaceous Adenocarcinomas

Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma, Sebaceous".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Adenocarcinoma, Sebaceous [C04.557.470.200.025.105]
Neoplasms, Adnexal and Skin Appendage [C04.557.470.550]
Adenocarcinoma, Sebaceous [C04.557.470.550.105]

Below are MeSH descriptors whose meaning is related to "Adenocarcinoma, Sebaceous".

Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma, Sebaceous".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Adenocarcinoma, Sebaceous" by people in this website by year, and whether "Adenocarcinoma, Sebaceous" was a major or minor topic of these publications.

Bar chart showing 28 publications over 16 distinct years, with a maximum of 5 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	2	0	2
2004	2	0	2
2005	1	0	1
2006	1	0	1
2007	1	0	1
2008	1	0	1
2009	1	1	2
2010	1	0	1
2011	1	0	1
2012	2	0	2
2013	1	2	3
2015	3	0	3
2016	1	0	1
2017	1	0	1
2019	5	0	5
2020	1	0	1

Below are the most recent publications written about "Adenocarcinoma, Sebaceous" by people in Profiles.

Xu S, Moss TJ, Laura Rubin M, Ning J, Eterovic K, Yu H, Jia R, Fan X, Tetzlaff MT, Esmaeli B. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis. Mod Pathol. 2020 07; 33(7):1256-1263.

View in: PubMed
Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol. 2019 12; 20(12):e699-e714.

View in: PubMed
Sa HS, Tetzlaff MT, Esmaeli B. Predictors of Local Recurrence for Eyelid Sebaceous Carcinoma: Questionable Value of Routine Conjunctival Map Biopsies for Detection of Pagetoid Spread. Ophthalmic Plast Reconstr Surg. 2019 Sep/Oct; 35(5):419-425.

View in: PubMed
Cheung JJC, Esmaeli B, Lam SC, Kwok T, Yuen HKL. The practice patterns in the management of sebaceous carcinoma of the eyelid in the Asia Pacific region. Eye (Lond). 2019 09; 33(9):1433-1442.

View in: PubMed
Bhardwaj M, Sen S, Chosdol K, Bakhshi S, Pushker N, Sharma A, Kashyap S, Bajaj MS, Singh VK. Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma. Br J Ophthalmol. 2020 06; 104(6):879-884.

View in: PubMed
Zhou C, Wu F, Chai P, Shi Y, Ye J, Shi X, Tan J, Ding Y, Luo Y, Esmaeli B, Jia R, Fan X. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients. J Am Acad Dermatol. 2019 Jun; 80(6):1608-1617.e1.

View in: PubMed
Broekaert SM, Flux K, Kyrpychova L, Kacerovska D, Ivan D, Schön MP, Ströbel P, Michal M, Denisjuk N, Kerl K, Kazakov DV. Squared-Off Nuclei and "Appliqué" Pattern as a Histopathological Clue to Periocular Sebaceous Carcinoma: A Clinicopathological Study of 50 Neoplasms From 46 Patients. Am J Dermatopathol. 2017 Apr; 39(4):275-278.

View in: PubMed
Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol. 2016 09; 240(1):84-95.

View in: PubMed
Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopathol. 2015 Nov; 37(11):809-21.

View in: PubMed
Tetzlaff MT, Curry JL, Yin V, Pattanaprichakul P, Manonukul J, Uiprasertkul M, Manyam GC, Wani KM, Aldape K, Zhang L, Prieto VG, Esmaeli B. Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs. JAMA Ophthalmol. 2015 Oct; 133(10):1109-16.

View in: PubMed

People

Explore

Similar Concepts

Top Journals